GLP1R and type 2 diabetes mellitus: Recent studies have found discontinuation rates ranging from 37% to 81%, depending on the population, data source, and time period considered.20,21,22,23,24,27 The finding of an increased discontinuation rate for GLP-1 RAs among patients without type 2 diabetes and with adverse GI adverse events is also similar to that noted in previous studies.23